Medication Administration Considerations for Patients Receiving Enteral Tube Feedings

Hospital Pharmacy

Volumn 39, Issue 1, 2004, Pages

  Dickerson, Roland N ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMPHOTERICIN B; BROMPHENIRAMINE; CHLORAL HYDRATE; CIMETIDINE; CIPROFLOXACIN; DEXTROMETHORPHAN; DOCUSATE SODIUM; GLUCONATE POTASSIUM; GUAIFENESIN; IRON; ISONIAZID; LEVOFLOXACIN; LITHIUM CITRATE; METAL ION; METOCLOPRAMIDE; OFLOXACIN; PARACETAMOL; PHENYLEPHRINE; PHENYTOIN; POTASSIUM CHLORIDE; POTASSIUM IODIDE; PSEUDOEPHEDRINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SODIUM DIHYDROGEN PHOSPHATE; SORBITOL; THEOPHYLLINE; TRIPROLIDINE; UNINDEXED DRUG; WARFARIN;

CLINICAL PRACTICE; CRITICAL ILLNESS; DIARRHEA; DRUG FORMULATION; DRUG USE; ELIXIR; ENTERIC FEEDING; FEEDING APPARATUS; HUMAN; OSMOTIC STRESS; REVIEW; TUBE FEEDING;

EID: 1642454803     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857870403900111     Document Type: Review

References (49)

1. Estoup M. Approaches and limitations of medication delivery in patients with enteral feeding tubes. Crit Care Nurse. 1994;14:68-72,77-9.
2. Gora ML, Tschampel MM, Visconti JA. Considerations of drug therapy in patients receiving enteral nutrition. Nutr Clin Pract. 1989;4:105-10.
3. Smith CH, Bidlack WR. Dietary concerns associated with the use of medications. J Am Diet Assoc. 1984;84:901-14.
4. Engle KK, Hannawa TE. Techniques for administering oral medications to critical care patients receiving continuous enteral nutrition. Am J Health Syst Pharm. 1999;56:1441-4.
5. Beckwith MC, Barton RG, Graves C. A guide to drug therapy in patients with enteral feeding tubes: Dosage form selection and administration methods. Hosp Pharm. 1997;32:57-64.
6. Lutomski DM, Gora ML, Wright SM, et al. Sorbitol content of selected oral liquids. Ann Pharmacother. 1993;27:269-74.
7. Miller SJ, Oliver AD. Sorbitol content of selected sugar-free liquid medications. Hosp Pharm. 1993;28:741-4.
8. Hill DB, Henderson LM, McClain CJ. Osmotic diarrhea induced by sugar-free theophylline solution in critically ill patients. JPEN J Parenter Enteral Nutr. 1991;15:332-6.
9. Edes TE, Walk BE, Austin JL. Diarrhea in tube-fed patients: Feeding formula not necessarily the cause. Am J Med. 1990;88:91-3.
10. Dickerson RN, Melnik G. Osmolality of oral drug solutions and suspensions. Am J Hosp Pharm. 1988;45:832-4.
11. Holtz L, Milton J, Sturek JK. Compatibility of medications with enteral feedings. JPEN J Parenter Enteral Nutr. 1987;11:183-6.
12. Niemiec PW, Jr., Vanderveen TW, Morrison JI, et al. Gastrointestinal disorders caused by medication and electrolyte solution osmolality during enteral nutrition. JPEN J Parenter Enteral Nutr. 1983;7:387-9.
13. White KC, Harkavy KL. Hypertonic formula resulting from added oral medications. Am J Dis Child. 1982;136:931-3.
14. Keohane PP, Attrill H, Love M, et al. Relation between osmolality of diet and gastrointestinal side effects in enteral nutrition. BMJ (Clin Res Ed). 1984;288:678-80.
15. Pesola GR, Hogg JE, Eissa N, et al. Hypertonic nasogastric tube feedings: Do they cause diarrhea? Crit Care Med. 1990;18:1378-82.
16. Guenter PA, Settle RG, Perlmutter S, et al. Tube feeding-related diarrhea in acutely III patients. JPEN J Parenter Enteral Nutr. 1991;15:277-80.
17. Dickerson RN, Tidwell AC, Brown RO. Adverse effects from inappropriate medication administration via a jejunostomy feeding tube. Nutr Clin Pract. 2003;18:402-8.
18. Mitchell JE. Oral dosage forms that should not be crushed: 1998 update. Hosp Pharm. 1998;33:399-415.
19. Chun AH, Shi HH, Achari R, et al. Lansoprazole: Administration of the contents of a capsule dosage formulation through a nasogastric tube. Clin Ther. 1996;18:833-42.
20. Phillips JO, Olsen KM, Rebuck JA, et al. A randomized, pharmacokinetic and pharmacodynamic, cross-over study of duodenal or jejunal administration compared to nasogastric administration of omeprazole suspension in patients at risk for stress ulcers. Am J Gastroenterol. 2001;96:367-72.
21. McAndrews KL, Jr., Eastham JH. Omeprazole and lansoprazole suspensions for nasogastric administration. Am J Health Syst Pharm. 1999;56:81.
22. Dunn A, White CM, Reddy P, et al. Delivery of omeprazole and lansoprazole granules through a nasogastric tube in vitro. Am J Health Syst Pharm. 1999;56:2327-30.
23. Quercia RA, Fan C, Liu X, et al. Stability of omeprazole in an extemporaneously prepared oral liquid. Am J Health Syst Pharm. 1997;54:1833-6.
24. Cutie AJ, Altman E, Lenkel L. Compatibility of enteral products with commonly employed drug additives. JPEN J Parenter Enteral Nutr. 1983;7:186-91.
25. Burns PE, McCall L, Wirsching R. Physical compatibility of enteral formulas with various common medications. J Am Diet Assoc. 1988;88:1094-6.
26. Altman E, Cutie AJ. Compatibility of enteral products with commonly employed drug additives. Nutr Supp Serv. 1984;4:8-17.
27. Fagerman KE, Ballou AE. Drug compatibilities with enteral feeding solutions coadministered by tube. Nutr Supp Serv. 1988;8:31-2.
28. Healy DP, Brodbeck MC, Clendening CE. Ciprofloxacin absorption is impaired in patients given enteral feedings orally and via gastrostomy and jejunostomy tubes. Antimicrob Agents Chemother. 1996;40:6-10.
29. Mueller BA, Brierton DG, Abel SR, et al. Effect of enteral feeding with ensure on oral bioavailabilities of ofloxacin and ciprofloxacin. Antimicrob Agents Chemother. 1994;38:2101-5.
30. Mimoz O, Binter V, Jacolot A, et al. Pharmacokinetics and absolute bioavailability of ciprofloxacin administered through a nasogastric tube with continuous enteral feeding to critically ill patients. Intensive Care Med. 1998;24:1047-51.
31. Faraji B, Yu PP. Serum phenytoin levels of patients on gastrostomy tube feeding. J Neurosci Nurs. 1998;30:55-9.
32. Bauer LA. Interference of oral phenytoin absorption by continuous nasogastric feedings. Neurology. 1982;32:570-2.
33. Maynard GA, Jones KM, Guidry JR. Phenytoin absorption from tube feedings. Arch Intern Med. 1987;147:1821.
34. Sneed RC, Morgan WT. Interference of oral phenytoin absorption by enteral tube feedings. Arch Phys Med Rehabil. 1988;69:682-4.
35. Hooks MA, Longe RL, Taylor AT, et al. Recovery of phenytoin from an enteral nutrient formula. Am J Hosp Pharm. 1986;43:685-8.
36. Cacek AT, DeVito JM, Koonce JR. In vitro evaluation of nasogastric administration methods for phenytoin. Am J Hosp Pharm. 1986;43:689-92.
37. Penrod LE, Allen JB, Cabacungan LR. Warfarin resistance and enteral feedings: Two case reports and a supporting in vitro study. Arch Phys Med Rehabil. 2001;82:1270-3.
38. Petretich DA. Reversal of Osmolite-warfarin interaction by changing warfarin administration time. Clin Pharm. 1990;9:93.
39. Kuhn TA, Garnett WR, Wells BK, et al. Recovery of warfarin from an enteral nutrient formula. Am J Hosp Pharm. 1989;46:1395-9.
40. Cohn SM, Sawyer MD, Burns GA, et al. Enteric absorption of ciprofloxacin during tube feeding in the critically ill. J Antimicrob Chemother. 1996;38:871-6.
41. Nyffeler MS. Ciprofloxacin use in the enterally fed patient. Nutr Clin Pract. 1999;14:73-7.
42. Pugh CB. Phenytoin and enteral feedings: A clinically significant interaction. Hosp Pharm. 1989;24:562-9.
43. Bertino JS, Naderer O. Is the phenytoin-enteral feeding formula interaction a myth? [letter]. Nutr Clin Pract. 1996;11:175-6.
44. Marvel ME, Bertino JS, Jr. Comparative effects of an elemental and a complex enteral feeding formulation on the absorption of phenytoin suspension. JPEN J Parenter Enteral Nutr. 1991;15:316-8.
45. Krueger KA, Garnett WR, Comstock TJ, et al. Effect of two administration schedules of an enteral nutrient formula on phenytoin bioavailability. Epilepsia. 1987;28:706-12.
46. Hatton J, Magnusson B. Response to Drs. Bertino and Naderer [letter]. Nutr Clin Pract. 1996;11:176.
47. Lee M, Schwartz RN, Sharifi R. Warfarin resistance and vitamin K. Ann Intern Med. 1981;94:140-1.
48. Zallman JA, Lee DP, Jeffrey PL. Liquid nutrition as a cause of warfarin resistance. Am J Hosp Pharm. 1981;38:1174.
49. Parr MD, Record KE, Griffith GL, et al. Effect of enteral nutrition on warfarin therapy. Clin Pharm. 1982;1:274-6.